H.R. 9561

H.R. 9561: To direct the Secretary of Health and Human Services to conduct a study on the feasibility of developing an accurate and reliable standardized test for detecting tuberculosis in tissue from a human cadaver, and for other purposes.

Introduced John Moolenaar (R) HOUSE_BILL — 119th Congress
Plain English Summary

H.R. 9561 is a bill that directs the Secretary of Health and Human Services to conduct a study on whether it is possible to create a standardized test that can accurately and reliably detect tuberculosis in tissue samples taken from human cadavers. The bill aims to explore the feasibility of such a test, which could have implications for public health and disease management.

Positive Media Summary

Media coverage has highlighted the potential public health benefits of developing a reliable tuberculosis test for cadaver tissue, emphasizing that such advancements could improve disease tracking and control efforts. Supporters argue that this research could lead to better understanding and management of tuberculosis, especially in cases where traditional testing methods are not applicable.

Negative Media Summary

Critics have raised concerns about the necessity and ethical implications of conducting studies on human cadavers for tuberculosis testing. Some argue that the focus should be on improving existing testing methods and treatment options for living patients rather than exploring cadaver studies. There are also worries about the allocation of federal resources to this study amidst other pressing health issues.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Health

The analysis of H.R. 9561 reveals no direct industry overlaps between the sponsor, John Moolenaar, and the bill's subject matter concerning tuberculosis testing. The top donor industries for Moolenaar do not intersect with the health and human services focus of the bill. Additionally, while there is lobbying activity in the health sector, the contributions from lobbyists such as the American Physical Therapy Association ($312,662) and ID.ME, LLC ($60,000) do not indicate a direct financial interest in tuberculosis testing. This lack of direct financial ties suggests a low risk of conflicts of interest. Voters should be aware that while lobbying exists, it does not directly correlate with the specific aims of the bill, indicating that the motivations behind the legislation may not be influenced by donor interests.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
AMERICAN PHYSICAL THERAPY ASSOCIATION AMERICAN PHYSICAL THERAPY ASSOCIATION $312,662
STE NORTH AMERICA, INC. (FORMERLY ST ENGINEERING NORTH AMERICA, INC.) STE NORTH AMERICA, INC. (FORMERLY ST ENGINEERING NORTH AMERICA, INC.) $210,000
ID.ME, LLC CORNERSTONE GOVERNMENT AFFAIRS, INC. $60,000
BLUE WATER AUTONOMY, INC. CORNERSTONE GOVERNMENT AFFAIRS, INC. $60,000
POLK COUNTY, IOWA CORNERSTONE GOVERNMENT AFFAIRS, INC. $30,000
GEORGIA POWER COMPANY CORNERSTONE GOVERNMENT AFFAIRS, INC. $20,000
ADVANCING MENTAL HEALTH FOR MILITARY FAMILIES, LLC CORNERSTONE GOVERNMENT AFFAIRS, INC. $10,000
TOWN OF PROSPERITY, SC LAKE SHORE STRATEGIES, LLC undisclosed
CITY OF FOREST ACRES LAKE SHORE STRATEGIES, LLC undisclosed
COLLETON COUNTY LAKE SHORE STRATEGIES, LLC undisclosed
NEWBERRY COUNTY LAKE SHORE STRATEGIES, LLC undisclosed
CITY OF EASLEY LAKE SHORE STRATEGIES, LLC undisclosed
TOWN OF IRMO, SC LAKE SHORE STRATEGIES, LLC undisclosed
RECORDED FUTURE, INC. RECORDED FUTURE, INC. undisclosed
CITY OF MARION, IOWA CORNERSTONE GOVERNMENT AFFAIRS, INC. undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding John Moolenaar, ranked by total contributions.

Health Professionals $240,000,000
Individuals: $240,000,000 PACs: $0
Retired $75,000,000
Individuals: $75,000,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us